Selected References: Butler DC, et al. 2014. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 70(3):417 e1-10. Carter TC, et al. 2008. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol. 198:191-193. Cervi VF, et al. 2022. A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action. Drug …
El Blog del Bebé
Acerca de Nuestro Baby Blog
Cada persona quiere saber qué es lo mejor para su bebé, especialmente cuando se trata de saber cómo minimizar los riesgos de exposición. Nuestras historias cercanas están repletas de información práctica de nuestro personal rotativo de blogueros expertos de MotherToBaby. Cualquiera que sea el tema que esté buscando, nuestros blogs le proporcionarán una gran base para obtener más información.
Vibrio
Selected References: Centers for Disease Control and Prevention. 2024. Vibrio Infection. [Accessed January 2026]. Available at URL: https://www.cdc.gov/vibrio/hcp/clinical-overview/index.html Ciccarelli S, et al. 2013. Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infect Drug Resist 6:133-61. Ciglenecki I, et al. 2013. Cholera in pregnancy: Outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Hati. PLoS Negl Trop Dis …
Zika Virus
Selected References: Ades AE, et al. 2021. Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies. Lancet Infect Dis. 21(4):537-545. doi: 10.1016/S1473-3099(20)30432-1. Acosta Pérez E, et al. 2025. Adverse fetal and perinatal outcomes associated with Zika virus infection during pregnancy: an individual participant data meta-analysis. eClinicalMedicine, Volume 83, 103231 Alger J, et al. 2024. Neurodevelopmental assessment of normocephalic …
Fexofenadine
Selected References: Andersson NW et al. Association between fexofenadine use during pregnancy and fetal outcomes. JAMA Pediatr Aug 1;174(8):e201316. Erratum in: JAMA Pediatr 2020 Sep 1;174(9):913. Craig-McFeely PM, et al. 2001. Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997. Eur J Clin Pharmacol 57(4):313-320. Diav-Citrin O, et al. 2003. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a …
Zinc
Selected References: Abe S, et al. 2016. Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby. Cochrane database of systematic reviews; 2. Adams JB, et al. 2021. Evidence-Based Recommendations for an Optimal Prenatal Supplement for Women in the U.S., Part Two: Minerals. Nutrients; 13(6):1849. Aničić R, et al. 2025. Levels of Cu, Zn, and Se in Maternal and Cord Blood in Normal and Pathological Pregnancies: A Narrative …
